Validix says its AI claim gate can hold unsupported content
Co-founder Lluis Pallares says the patent-pending system is live at one unnamed pharmaceutical company, with a commercial platform planned for early 2027.
By RuntimeWire Staff · Published

Co-founder Lluis Pallares says the patent-pending system is live at one unnamed pharmaceutical company, with a commercial platform planned for early 2027.